Roivant Sciences ROIV
NASDAQ ROIV
$36.50 -0.48 (-1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Net Margin (2020 - 2026)

Updated

Roivant Sciences (ROIV) recorded Net Margin of -13164.84% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 2871.98 percentage points from -10292.86% a year earlier and down 25188.41 percentage points from the prior quarter.

Analysis

Roivant Sciences (ROIV) Net Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Roivant Sciences' Net Margin came in at -3534.96% as of Jun 30, 2026, down 1423.16 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -3629.19%, down 3037.23 percentage points from FY2025.

  • Annual Net Margin has a five-year change of -228.33 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Net Margin came in at -591.96% in FY2025 (-13886.14 pp), 13294.18% in FY2024 (+16494.40 pp), -3200.22% in FY2023 (-1671.33 pp) and -1528.89% in FY2022 (+1871.97 pp).
  • Quarterly Net Margin has ranged from -13301.20% in fiscal Q3 2026 to 32747.62% in fiscal Q3 2024 over the past five years.
  • On a year-over-year basis, Net Margin rose in two of the last eight quarters, with an average year-over-year change of -5698.88 percentage points.
  • Peak year-over-year performance for Net Margin in the last five years was a gain of 34811.97 percentage points in fiscal Q3 2024, against a drop of 30869.36 percentage points in fiscal Q3 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at 12023.57% (Q4 2026), -13301.20% (Q3 2026) and -7225.91% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Roivant Sciences 26.72 Bn 27.41 Bn 1.16 Mn -13,164.84%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13,164.84%
Mar 31, 2026 12,023.57%
Dec 31, 2025 -13,301.20%
Sep 30, 2025 -7,225.91%
Jun 30, 2025 -10,292.86%
Mar 31, 2025 -2,727.54%
Dec 31, 2024 1,878.25%
Sep 30, 2024 -5,143.78%
Jun 30, 2024 1,192.70%
Mar 31, 2024 -1,675.33%
Dec 31, 2023 32,747.62%
Sep 30, 2023 -8,342.30%
Jun 30, 2023 -1,349.50%
Dec 31, 2022 -2,064.36%
Sep 30, 2022 -2,326.58%
Jun 30, 2022 -7,682.54%
Mar 31, 2022 -2,928.14%
Dec 31, 2021 -1,168.96%
Sep 30, 2021 -1,490.53%
Jun 30, 2021 -1,062.48%
API Access

Roivant Sciences Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ROIV&period=max&api_key=YOUR_API_KEY